[MUSIC PLAYING] Chemotherapy is a very broad term used to describe agents that go into the veins through an IV to treat prostate cancer that has spread to other parts of the body. These medicines ...

Julie Brahmer, MD, discusses the unique features of the phase 3 CheckMate 9LA trial in patients with metastatic non–small cell lung cancer.

AstraZeneca has discontinued its CAPItello-280 phase three trial assessing Truqap, or capivasertib, in combination with docetaxel and androgen-deprivation therapy (ADT) for patients with metastatic ...

The Olympic champion who is battling terminal prostate cancer said he is acutely aware the illness will not disappear all of a sudden. But post chemotherapy he has been able to work on his ...

chemotherapy-induced menopause) or hormonal treatments, such as tamoxifen or aromatase inhibitors for breast cancer or androgen ablation for prostate cancer. The effects of chemotherapy-associated ...

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on ...

Recently, licensed and emerging treatments for metastatic castrate-resistant prostate cancer are transforming ... during or after docetaxel-based chemotherapy. Two agents (cabazitaxel and ...

More debate about whether the lowest-risk prostate cancers should ... KRAS G12C-mutated metastatic colorectal cancer after specific chemotherapy regimens. The agency also approved acalabrutinib ...

The Food and Drug Administration (FDA) has expanded the approval of Pluvicto ® (lutetium Lu 177 vipivotide tetraxetan) to include patients with prostate ... to delay chemotherapy, in addition ...

Nauseef JT, Sun MP, Thomas C, et al. A phase I/II dose-escalation study of fractionated 225Ac-J591 for progressive metastatic castration-resistant prostate cancer in patients with prior treatment with ...

The University of Queensland will play a key role in a national effort to revolutionize treatment for men with prostate cancer.